The 89th Annual Meeting of JBS

Sep 25, 2016 - Sep 27, 2016
Sendai International Center/ Kawauchi Campus, Tohoku University

Search Criteria
Search Filters

2025 results (1061 - 1070)

[1P-266] Hair keratin KRT81 is expressed in breast cancer cells and it contributes to their invasiveness.

^○Naoki Nanashima¹, Kayo Horie¹, Toshiyuki Yamada², Takeshi Shimizu², Shigeki Tsuchida^2,3 (1.Dept. Biosci & Lab. Med., Hirosaki Univ. Grad. Sch. Health Sci., 2.Dept. Biochem. Genome Biol., Hirosaki Univ. Grad. Sch. Med., 3.Dept. Rehab. sci., Hirosaki Univ. Health & Welfare)

The 89th Annual Meeting of JBS |Sun. Sep 25, 2016 2:45 PM - 3:45 PM

[1P-267] Examination of therapeutic strategies targeting to differentiation into cancer associated fibroblasts from mesenchymal stem cell

^○Shigeki Aoki, Kaori Aoto, Kousei Ito (Lab. of Biopharm., Grad. Sch. of Pharm. Sci., Chiba Univ.)

The 89th Annual Meeting of JBS |Sun. Sep 25, 2016 1:30 PM - 2:45 PM

[1P-268] Tumor responsiveness to mevalonate pathway inhibitors require overexpression of the Arf6 pathway

^○Ari Hashimoto, Shigeru Hashimoto, Tsukasa Oikawa, Yutaro Otsuka, Haruka Handa, Yasuhito Onodera, Hisataka Sabe (Dept. of Mol. Biol., Hokkaido Univ. Grad. Sch. of Med.)

The 89th Annual Meeting of JBS |Sun. Sep 25, 2016 2:45 PM - 3:45 PM

[1P-269] Molecular design of highly selective peptide inhibitors against MMP-9

^○Yuta Sasaki, Shouichi Higashi (Grad. Sch. Nanobiosci., Yokohama city Univ.)

The 89th Annual Meeting of JBS |Sun. Sep 25, 2016 1:30 PM - 2:45 PM

[1P-270] Glucocorticoids enhances sensitivity to antitumor drugs by disrupting cellular energy metabolism.

^○Michie Morita, Shigeki Aoki, Takuya Hirao, Moemi Kawaguchi, Kosei Ito (Lab. of Biopharm., Grad. Sch. of Pharm. Sci., Chiba Univ.)

The 89th Annual Meeting of JBS |Sun. Sep 25, 2016 2:45 PM - 3:45 PM

[1P-271(1T06-05)] Progranulin and granulin-like protein are novel angiogenic factors derived from human mesothelioma cells

^○Ryoji Eguchi¹, Takashi Nakano², Ichiro Wakabayashi¹ (1.Dept. Env. Prev. Med., Hyogo Coll. Med., 2.Div. Resp. Med., Dep. Int. Med., Hyogo Coll. Med.)

The 89th Annual Meeting of JBS |Sun. Sep 25, 2016 1:30 PM - 2:45 PM

[1P-272(1T06-06)] Stepwise accumulation of somatic mutations in non-neoplastic tissue and malignant tumor during hepatic carcinogenesis

^○Yosuke Hirotsu¹, Hitoshi Mochizuki^1,2, Kenji Amemiya¹, Masao Omata^1,2,3 (1.Genome Analysis Center, Yamanashi Prefectural Central Hospital, 2.Department of Gastroenterology, Yamanashi Prefectural Central Hospital, 3.The University of Tokyo)

The 89th Annual Meeting of JBS |Sun. Sep 25, 2016 2:45 PM - 3:45 PM

[1P-273] Decreased expression of Betaglycan enhances both tumor forming ability and cell motility in renal cell carcinoma

^○Jun Nishida, Shogo Ehata, Kohei Miyazono (Dept. Mol. Path., Grad. Sch. Med., Univ. Tokyo)

The 89th Annual Meeting of JBS |Sun. Sep 25, 2016 1:30 PM - 2:45 PM

[1P-274] Suppressive effect of CK2 inhibitor on angiogenic function of CXCL1

^○Hiromi Ashino^1,2, Katsurou Iwase¹, Tomio Ono², Masak Takiguchi¹ (1.Dept. of Biochem. Sch. of Med., Univ. of Chiba, 2.Lab.Transgenic Technol., Tokyo Metropol. Inst. of Med. Sci.)

The 89th Annual Meeting of JBS |Sun. Sep 25, 2016 2:45 PM - 3:45 PM

[1P-275(1T06-02)] Design of highly selective and strong peptide inhibitors against MMP-2 by replacing amino acid residues of APP-IP

^○Yuki Kondo, Shouichi Higashi (Grad. Sch. Nanobiosci., Yokohama city Univ.)

The 89th Annual Meeting of JBS |Sun. Sep 25, 2016 1:30 PM - 2:45 PM

2025 results (1061 - 1070)